Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway

Yu-Li Shen,Yi-ping Jiang,Xiao-Qin Li,Su-Juan Wang,Ming-Hua Ma,Chun-Yan Zhang,Jian-Yong Zhu,Khalid Rahman,Li-Jun Zhang,Xin Luan,Hong Zhang
DOI: https://doi.org/10.3389/fphar.2021.789192
IF: 5.6
2021-11-18
Frontiers in Pharmacology
Abstract:[This corrects the article DOI: 10.3389/fphar.2019.01596.].
pharmacology & pharmacy
What problem does this paper attempt to address?